6533b82cfe1ef96bd128f5ce

RESEARCH PRODUCT

Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis

Ofelia Baniandrés-rodríguezJaime Vilar-alejoRaquel RiveraJosé Manuel CarrascosaEsteban DaudénEnrique Herrera-acostaAntonio Sahuquillo-torralbaFran J. Gómez-garcíaLula María Nieto-benitoPablo De La CuevaJosé Luis López-estebaranzIsabel BelinchónMarta Ferrán FarrésMercè AlsinaLourdes Rodríguez Fernández-freireGregorio CarreteroCarmen García-donosoFerrán BallescáMar Llamas-velascoEnrique Herrera-ceballosRafael Botella-estradaDiana Patricia Ruiz-genaoJosep Riera-monroigMiguel ÁNgel Descalzo GallegoIgnacio García-dovalEsteban DaudénMar Llamas-velascoCristina SantamaríaGregorio CarreteroJaime Vilar-alejoBlanca Madrid ÁLvarezRaquel RiveraCarmen García-donosoMa Del Mar Onteniente GomisDiana Batista CabreraCarlos FerrándizJosé Manuel CarrascosaFerrán BallescáPablo De La CuevaPatricia Molina MejíasIsabel BelinchónCarlos García GinerAlfred PerezFran J. Gómez-garcíaEnrique Herrera-ceballosEnrique Herrera-acostaEliseo Martínez-garcíaCristina SánchezJosé Luis López-estebaranzDiana Patricia Ruiz-genaoElena García ZamoraMarta Ferrán FarrésMercè AlsinaJosep RieraSara Pedregosa FausteOfelia BaniandrésLula María Nieto BenitoDesiree MolinaJosé Luis Sánchez-carazoAntonio Sahuquillo-torralbaRafael Botella-estradaConrad Pujol MarcoNatalia Chaparro AguileraVerónica Massó LópezLourdes Rodríguez Fernández-freireAlmudena Mateu PuchadesSergio SantosMarina Sáez BellóÁNgeles Flórez MenéndezLaura SalgadoBeatriz González SixtoMa Teresa AbaldeLucia VilanovaAlexandra Perez MariñoNoemí EirisVicenta Prieto MarcosIgnacio García-dovalMiguel ÁNgel Descalzo GallegoMarina De Vega Martínez

subject

AdultMale2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)prospective cohortMEDLINEDermatologyregistryimmunosuppressive agentsSeverity of Illness IndexCOVID-19 (Malaltia)ArticleCohort StudiesInternal medicinePandemicPsoriasisHumansMedicinebiologic therapyRegistriesAgedbusiness.industryIncidenceIncidence (epidemiology)COVID-19COVID-19 Psoriasis biologic therapy immunosuppressive agents pharmacovigilance prospective cohort registryMiddle AgedSpainpharmacovigilanceFemalebusinessPsoriasi -- TractamentCohort study10.1016/j.jaad.2020.10.046http://dx.doi.org/10.1016/j.jaad.2020.10.046